Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

IEX earnings analysis

Filed April 29, 2026 · Our reading of the company's report

The latest report

IDEX Corporation reported strong financial results for Q1 2026, with revenues of $886.9 million surpassing expectations and up 9% year-over-year. Adjusted EPS also increased to $2.00, marking a 14% rise from Q1 2025.…

Read full summary

IDEX Corporation reported strong financial results for Q1 2026, with revenues of $886.9 million surpassing expectations and up 9% year-over-year. Adjusted EPS also increased to $2.00, marking a 14% rise from Q1 2025. Segment growth was driven primarily by the Health & Science Technologies sector, while the Fluid & Metering segment saw modest growth, and the Fire & Safety segment experienced a slight decline.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

46% Gross margin Operating margin Oct 2022 Apr 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

From revenue to operating profit

Where each $100 of revenue went in this report.

Of every $100 of revenue Cost of sales $55 Operating expenses $25 Left as operating profit $20

Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Oct 2022 Apr 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$2.0
Segment
Health & Science Technologies
Segment
Fluid & Metering Technologies
Segment
Fire & Safety/Diversified Products

What stood out

  • Strong Revenue Growth

    Revenue reached $886.9 million, up 9% from $814.3 million in the prior year.

  • EPS Beat Consensus

    Adjusted EPS of $2.00 surpassed estimates and increased 14% compared to $1.75 in Q1 2025.

  • Segment Performance Positive

    Health & Science Technologies grew 17%, driven by strength in data centers and semiconductors.

  • Healthy Operating Margins

    Gross margin stood at 44.9%, slightly down by 40 bps from the prior year, but operating income grew 21%.

  • Free Cash Flow Remains Solid

    Free cash flow was reported at $86.0 million despite a slight decline year-over-year.

  • Shareholder Returns Increased

    Returned $129.1 million to shareholders through repurchases and dividends.

What to watch

  • Segment Volatility

    Fire & Safety/Diversified Products segment declined 2%, with lower volumes affecting growth.

  • Rising Costs Impact Margins

    Gross margin decreased to 44.9% from 45.3%, affected by unfavorable product mix.

  • Tariff Risks Remain

    Ongoing changes in tariffs following recent Supreme Court rulings could impact costs.

Management's outlook

Outlook deferred to earnings press release / call.

Earlier filings 4

10-K · February 19, 2026

IDEX describes a strategy focused on niche, mission-critical engineered products, organic growth and strategic acquisitions (e.g., Micro-LAM acquired July 2025) and emphasizes decentralized operating units united by…

10-Q · October 29, 2025

IDEX reported third-quarter net sales of $878.7 million and diluted EPS of $1.70 for the three months ended September 30, 2025. Revenue and segment Adjusted EBITDA were higher year-over-year (net sales up from $798.2M;…

10-K · February 20, 2025

IDEX presents a diversified, niche-industrial strategy organized into three reportable segments (FMT, HST, FSDP) focused on organic growth plus strategic acquisitions. The 2024 10‑K highlights a roughly even…

10-Q · October 30, 2024

IDEX reported third-quarter net sales of $798.2 million (up $4.8 million vs. Q3 2023) with gross profit of $353.9 million and diluted EPS of $1.57, down from $2.75 a year ago. Operating income declined to $168.0 million…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.